## Legislative bill overview

LB238 seeks to amend the Nebraska Revised Statutes to provide for the establishment of a state-wide prescription drug affordability board. Its primary objective is to address the rising costs of prescription medications and ensure that Nebraskans have access to affordable drugs. The bill proposes that the board will evaluate the affordability of certain high-cost prescription drugs, engage with manufacturers, and potentially set upper payment limits for these drugs to alleviate financial burdens on consumers and the healthcare system.

## Why is this important

This bill is significant as the escalating costs of prescription drugs have been a persistent issue affecting public health and financial stability for many families. By establishing a dedicated board, Nebraska aims to create a structured approach to tackling drug pricing, which could lead to more affordable access for residents. This legislation may also set a precedent for other states facing similar challenges, potentially influencing national discussions on drug pricing reform.

## Potential points of contention

• Concerns about the board's authority and its potential overreach into private sector pricing strategies.


• Possible pushback from pharmaceutical companies regarding the impact on innovation and drug development.


• Debate on how the board will determine which drugs to evaluate and the criteria for affordability.


• Potential implications for health insurance providers and the overall healthcare market dynamics.